Trial Profile
Effect of Rituximab in the Treatment of Resistant Ocular Inflammatory Lesions of Behcet's Disease (Pilot Study)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2011
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Azathioprine; Cyclophosphamide; Methotrexate; Prednisolone
- Indications Behcet's syndrome; Posterior uveitis; Retinal vascular occlusion
- Focus Therapeutic Use
- 21 Jul 2011 New trial record